3D Systems Corp. is a leading provider of 3D content-to-print solutions including 3D printers, print materials, on-demand custom parts services & 3D authoring solutions for professionals & consumers, world wide. It provides scanners for a variety of medical and mechanical X-Ray film digital archiving. The company's print engines comprise stereolithography, selective laser sintering, multi-jet modeling & ZPrinters. Its 3D printers convert soft-data into physical objects from engineered plastic, metals, ceramics & edibles. It caters to manufacturers of automotive, aerospace, computer, electronic, defense, education, consumer, energy & healthcare products, original equipment manufacturers, government agencies, universities, independent service bureaus and individuals. The Product unit offers 3D printers, materials, software, haptic design tools, 3D scanners & virtual surgical simulators. The Service unit offers maintenance & service support, periodic hardware/software updates, printer installations & trainings....
+See More2017-07-01 08:40:00 Saturday ET

The Economist interviews President Donald Trump and spots the keyword *reciprocity* in many aspects of Trumponomics from trade and taxation to infrastructur
2018-12-09 08:44:00 Sunday ET

President Trump meets with Chinese President Xi again at the G20 summit in the city of Buenos Aires, Argentina, in late-November 2018. President Donald Trum
2019-09-07 17:37:00 Saturday ET

Federal Reserve Chair Jerome Powell announces the monetary policy decision to lower the federal funds rate by a quarter point to 2%-2.25%. This interest rat
2019-10-31 13:38:00 Thursday ET

AYA Analytica finbuzz podcast channel on YouTube October 2019 In this podcast, we discuss several topical issues as of October 2019: (1)
2022-04-05 17:39:00 Tuesday ET

Corporate diversification theory and evidence A recent strand of corporate diversification literature spans at least three generations. The first generat
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be